Skip to main content

Advertisement

Log in

Effect of testosterone therapy on the urinary bladder in experimental hypogonadism of rats

  • Original Paper
  • Published:
Journal of Molecular Histology Aims and scope Submit manuscript

Abstract

Testosterone (T) deficiency is prevalent particularly in elderly men and lead to physical and sexual morbidities. Although low levels of T are associated with low urinary tract symptoms, the correlation between T deficiency and bladder dysfunction is not clearly identified. The aim of this study was to investigate the effect of high dose testosterone replacement therapy (TRT) on the histological structure of the UB in castrated rats. Twenty-five adult male rats were divided into three groups: control, castrated and castrated + TRT. T was administrated in high dose (100 mg/kg) two intramuscular injections/week for 60 days. UB sections were prepared and stained with H&E, Masson’s trichrome and immunohistochemical detection of Cytokeratin 20 (Ck20). All data were morphometrically and statistically analyzed. In castrated group, significant atrophy of the urothelium (P < 0.001) accompanied with widening of the corium were observed. The smooth muscle appeared thin with marked increase in the collagen fibers. On treating the castrated group with TRT, atypical Ck20 expression as well as significant increase in urothelial thickness (P < 0.05) and smooth muscle/collagen ratio (P < 0.001) were detected. In castrated rat model, high dose TRT has a positive effect on the UB smooth muscle rather than the urothelium which acquired atypical patterns.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  • Bancroft JD, Layton C (2013) The Hematoxylin and eosin. In: Suvarna SK, Layton C and Bancroft JD (eds), Theory & Practice of histological techniques. 7th ed., Churchill Livingstone of El Sevier, Philadelphia, Ch.10 and 11, pp 173–214

  • Callies F, Kollenkirchen U, von zur Muhlen C et al (2003) Testosterone undecanoate: a useful tool for testosterone administration in rats. Exp Clin Endocrinol Diabetes 111:203–208

    Article  CAS  PubMed  Google Scholar 

  • Cayan F, Tek M, Balli E et al (2008) The effect of testosterone alone and testosterone + estradiol therapy on bladder functions and smooth muscle/collagen content in surgically menopause induced rats. Maturitas 60:248–252

    Article  CAS  PubMed  Google Scholar 

  • Celayir S, Ilce Z, Dervisoglu S (2002) The sex hormone receptors in the bladder in childhood - I: preliminary report in male subjects. Eur J Pediatr Surg 12:312–317

    Article  CAS  PubMed  Google Scholar 

  • Chamness SL, Ricker DD, Crone JK et al (1995) The effect of androgen on nitric oxide synthase in the male reproductive tract of the rat. Fertil Steril 63:1101–1107

    CAS  PubMed  Google Scholar 

  • Chang C, Lee SO, Yeh S et al (2014) Androgen receptor (AR) differential roles in hormone-related tumors including prostate, bladder, kidney, lung, breast and liver. Oncogene 33:3225–3234

    Article  CAS  PubMed  Google Scholar 

  • Corona G, Rastrelli G, Forti G et al (2011) Update in testosterone therapy for men. J Sex Med 8: 639-654; quiz 655

  • Das AK, Leggett RE, Whitbeck C et al (2002) Effect of doxazosin on rat urinary bladder function after partial outlet obstruction. Neurourol Urodyn 21:160–166

    Article  CAS  PubMed  Google Scholar 

  • de Barros CA, Lorenzetti F, Ortiz V et al (2013) Testosterone supplementation’s effects on age-related bladder remodeling-experimental study in rats. Aging Male 16:102–107

    Article  PubMed  Google Scholar 

  • de Deus JM, Girao MJ, Sartori MG et al (2003) Glycosaminoglycan profile in bladder and urethra of castrated rats treated with estrogen, progestogen, and raloxifene. Am J Obstet Gynecol 189:1654–1659

    Article  PubMed  Google Scholar 

  • Filippi S, Morelli A, Sandner P et al (2007) Characterization and functional role of androgen-dependent PDE5 activity in the bladder. Endocrinology 148:1019–1029

    Article  CAS  PubMed  Google Scholar 

  • Gallo CB, Miranda AF, Felix-Patricio B et al (2012) Effects of castration and hormone replacement in the urinary bladder of rats: structural, ultrastructural, and biochemical analysis. J Androl 33:684–690

    Article  CAS  PubMed  Google Scholar 

  • Giagulli VA, Triggiani V, Carbone MD et al (2011a) The role of long-acting parenteral testosterone undecanoate compound in the induction of secondary sexual characteristics in males with hypogonadotropic hypogonadism. J Sex Med 8:3471–3478

    Article  CAS  PubMed  Google Scholar 

  • Giagulli VA, Triggiani V, Corona G et al (2011b) Evidence-based medicine update on testosterone replacement therapy (TRT) in male hypogonadism: focus on new formulations. Curr Pharm Des 17:1500–1511

    Article  CAS  PubMed  Google Scholar 

  • Haider A, Gooren LJ, Padungtod P et al (2009) Concurrent improvement of the metabolic syndrome and lower urinary tract symptoms upon normalisation of plasma testosterone levels in hypogonadal elderly men. Andrologia 41:7–13

    Article  CAS  PubMed  Google Scholar 

  • Hall R, Andrews PLR, Hoyle CHV (2002) Effects of testosterone on neuromuscular transmission in rat isolated urinary bladder. Eur J Pharmacol 449:301–309

    Article  CAS  PubMed  Google Scholar 

  • Harnden P, Eardley I, Joyce AD et al (1996) Cytokeratin 20 as an objective marker of urothelial dysplasia. Br J Urol 78:870–875

    Article  CAS  PubMed  Google Scholar 

  • Jockenhovel F, Minnemann T, Schubert M et al (2009) Comparison of long-acting testosterone undecanoate formulation versus testosterone enanthate on sexual function and mood in hypogonadal men. Eur J Endocrinol 160:815–819

    Article  CAS  PubMed  Google Scholar 

  • Juan Y-S, Onal B, Broadaway S et al (2007) Effect of castration on male rabbit lower urinary tract tissue enzymes. Mol Cell Biochem 301:227–233

    Article  CAS  PubMed  Google Scholar 

  • Kalinchenko S, Vishnevskiy EL, Koval AN et al (2008) Beneficial effects of testosterone administration on symptoms of the lower urinary tract in men with late-onset hypogonadism: a pilot study. Aging Male 11:57–61

    Article  CAS  PubMed  Google Scholar 

  • Karazindiyanoglu S, Cayan S (2008) The effect of testosterone therapy on lower urinary tract symptoms/bladder and sexual functions in men with symptomatic late-onset hypogonadism. Aging Male 11:146–149

    Article  CAS  PubMed  Google Scholar 

  • Keast JR (1999) The autonomic nerve supply of male sex organs–an important target of circulating androgens. Behav Brain Res 105:81–92

    Article  CAS  PubMed  Google Scholar 

  • Koritsiadis G, Stravodimos K, Mitropoulos D et al (2008) Androgens and bladder outlet obstruction: a correlation with pressure-flow variables in a preliminary study. BJU Int 101:1542–1546

    Article  PubMed  Google Scholar 

  • Kunju LP, Lee CT, Montie J et al (2005) Utility of cytokeratin 20 and Ki-67 as markers of urothelial dysplasia. Pathol Int 55:248–254

    Article  PubMed  Google Scholar 

  • Lang Q, Liu Q, Xu N et al (2011) The antifibrotic effects of TGF-β1 siRNA on hepatic fibrosis in rats. Biochem Biophys Res Commun 409:448–453

    Article  CAS  PubMed  Google Scholar 

  • Li Y, Izumi K, Miyamoto H (2012) The role of the androgen receptor in the development and progression of bladder cancer. Jpn J Clin Oncol 42:569–577

    Article  PubMed  Google Scholar 

  • Litman HJ, Bhasin S, O’Leary MP et al (2007) An investigation of the relationship between sex-steroid levels and urological symptoms: results from the Boston Area Community Health survey. BJU Int 100:321–326

    Article  CAS  PubMed  Google Scholar 

  • Longhurst PA (2003) Functional development of the rat urinary bladder after pre- or postpubertal castration. Pharmacology 67:72–82

    Article  CAS  PubMed  Google Scholar 

  • Madeiro A, Girao M, Sartori M et al (2002) Effects of the association of androgen/estrogen on the bladder and urethra of castrated rats. Clin Exp Obstet Gynecol 29:117–120

    Article  CAS  PubMed  Google Scholar 

  • Magari T, Shibata Y, Arai S et al (2014) Time-dependent effects of castration on the bladder function and histological changes in the bladder and blood vessels. Asian J Androl 16:457–460

    Article  PubMed Central  PubMed  Google Scholar 

  • Mallofre C, Castillo M, Morente V et al (2003) Immunohistochemical expression of CK20, p53, and Ki-67 as objective markers of urothelial dysplasia. Mod pathol 16:187–191

    Article  PubMed  Google Scholar 

  • Matsuoka M, Tsukamoto H (1990) Stimulation of hepatic lipocyte collagen production by Kupffer cell-derived transforming growth factor beta: implication for a pathogenetic role in alcoholic liver fibrogenesis. Hepatology 11:599–605

    Article  CAS  PubMed  Google Scholar 

  • McKenney JK, Desai S, Cohen C et al (2001) Discriminatory immunohistochemical staining of urothelial carcinoma in situ and non-neoplastic urothelium: an analysis of cytokeratin 20, p53, and CD44 antigens. Am J Surg Pathol 25:1074–1078

    Article  CAS  PubMed  Google Scholar 

  • McVary K (2006) Lower urinary tract symptoms and sexual dysfunction: epidemiology and pathophysiology. BJU Int 97 Suppl 2: 23–28; discussion 44–45

  • Moll R (1991) Molecular diversity of cytokeratins: significance for cell and tumor differentiation. Acta Histochemica Supplementband 41:117–127

    CAS  PubMed  Google Scholar 

  • Morita T, Tsuchiya N, Tsujii T et al (1992) Changes of autonomic receptors following castration and estrogen administration in the male rabbit urethral smooth muscle. Tohoku J Exp Med 166:403–405

    Article  CAS  PubMed  Google Scholar 

  • Nahata A, Dixit VK (2012) Ameliorative effects of stinging nettle (Urtica dioica) on testosterone-induced prostatic hyperplasia in rats. Andrologia 44(Suppl 1):396–409

    Article  PubMed  Google Scholar 

  • Pradidarcheep W (2008) Lower urinary tract symptoms and its potential relation with late-onset hypogonadism. Aging Male 11:51–55

    Article  CAS  PubMed  Google Scholar 

  • Purves-Tyson TD, Arshi MS, Handelsman DJ et al (2007) Androgen and estrogen receptor-mediated mechanisms of testosterone action in male rat pelvic autonomic ganglia. Neuroscience 148:92–9104

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Rahman M, Miyamoto H, Chang C (2004) Androgen receptor coregulators in prostate cancer: mechanisms and clinical implications. Clin Cancer Res 10:2208–2219

    Article  CAS  PubMed  Google Scholar 

  • Rees RW, Foxwell NA, Ralph DJ et al (2003) Y-27632, a Rho-kinase inhibitor, inhibits proliferation and adrenergic contraction of prostatic smooth muscle cells. J Urol 170:2517–2522

    Article  CAS  PubMed  Google Scholar 

  • Salmi S, Santti R, Gustafsson JA et al (2001) Co-localization of androgen receptor with estrogen receptor beta in the lower urinary tract of the male rat. J Urol 166:674–677

    Article  CAS  PubMed  Google Scholar 

  • Samarakoon R, Overstreet JM, Higgins SP et al (2012) TGF-β1 → SMAD/p53/USF2 → PAI-1 transcriptional axis in ureteral obstruction-induced renal fibrosis. Cell Tissue Res 347:117–128

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Shen Z-J, Zhou X-L, Lu Y-L et al (2003) Effect of androgen deprivation on penile ultrastructure. Asian J Androl 5:33–36

    CAS  PubMed  Google Scholar 

  • Takyu S (1993) Effects of testosterone on the autonomic receptor-mediated function in lower urinary tract from male rabbits. Nihon Hinyokika Gakkai Zasshi 84:330–338

    CAS  PubMed  Google Scholar 

  • Tek M, Balli E, Cimen B et al (2010) The effect of testosterone replacement therapy on bladder functions and histology in orchiectomized mature male rats. Urology 75:886–890

    Article  PubMed  Google Scholar 

  • Tirabassi G, Delli Muti N, Corona G et al (2014) Androgen receptor gene CAG repeat polymorphism independently influences recovery of male sexual function after testosterone replacement therapy in postsurgical hypogonadotropic hypogonadism. J Sex Med 11:1302–1308

    Article  CAS  PubMed  Google Scholar 

  • Traish AM, Goldstein I, Kim NN (2007) Testosterone and erectile function: from basic research to a new clinical paradigm for managing men with androgen insufficiency and erectile dysfunction. Eur Urol 52:54–70

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Wen J, Jiang X, Dai Y et al (2010) Increased adenosine contributes to penile fibrosis, a dangerous feature of priapism, via A2B adenosine receptor signaling. FASEB J 24:740–749

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Yassin DJ, Doros G, Hammerer PG et al (2014) Long-term testosterone treatment in elderly men with hypogonadism and erectile dysfunction reduces obesity parameters and improves metabolic syndrome and health-related quality of life. J Sex Med 11:1567–1576

    Article  CAS  PubMed  Google Scholar 

  • Zhang Y, Chen J, Hu L et al (2012) Androgen deprivation induces bladder histological abnormalities and dysfunction via TGF-beta in orchiectomized mature rats. Tohoku J Exp Med 226:121–128

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

The authors have not made any acknowledgments.

Conflict of interest

There is no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ahmed A. M. Abdel-Hamid.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Abdel-Hamid, A.A.M., Ali, E.M.T. Effect of testosterone therapy on the urinary bladder in experimental hypogonadism of rats. J Mol Hist 46, 263–272 (2015). https://doi.org/10.1007/s10735-015-9617-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10735-015-9617-4

Keywords

Navigation